<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6929334</article-id>
    <article-id pub-id-type="publisher-id">3046</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-019-3046-4</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Methodology</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>DNLC: differential network local consistency analysis</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Lu</surname>
          <given-names>Jianwei</given-names>
        </name>
        <address>
          <email>jwlu33@hotmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Lu</surname>
          <given-names>Yao</given-names>
        </name>
        <address>
          <email>luyao@ieee.org</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Ding</surname>
          <given-names>Yusheng</given-names>
        </name>
        <address>
          <email>yushengding93@gmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xiao</surname>
          <given-names>Qingyang</given-names>
        </name>
        <address>
          <email>qingyang.xiao@emory.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Linqing</given-names>
        </name>
        <address>
          <email>likicode@gmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cai</surname>
          <given-names>Qingpo</given-names>
        </name>
        <address>
          <email>qingpo.cai@emory.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kong</surname>
          <given-names>Yunchuan</given-names>
        </name>
        <address>
          <email>yunchuan.kong@emory.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Bai</surname>
          <given-names>Yun</given-names>
        </name>
        <address>
          <email>yunba@pcom.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2502-1628</contrib-id>
        <name>
          <surname>Yu</surname>
          <given-names>Tianwei</given-names>
        </name>
        <address>
          <email>tianwei.yu@emory.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000000123704535</institution-id><institution-id institution-id-type="GRID">grid.24516.34</institution-id><institution>School of Software Engineering, </institution><institution>Tongji University, </institution></institution-wrap>Shanghai, China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000000123704535</institution-id><institution-id institution-id-type="GRID">grid.24516.34</institution-id><institution>Institute of Advanced Translational Medicine, </institution><institution>Tongji University, </institution></institution-wrap>Shanghai, China </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0941 6502</institution-id><institution-id institution-id-type="GRID">grid.189967.8</institution-id><institution>Department of Environmental Health, </institution><institution>Emory University, </institution></institution-wrap>Atlanta, GA USA </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0941 6502</institution-id><institution-id institution-id-type="GRID">grid.189967.8</institution-id><institution>Department of Biostatistics and Bioinformatics, </institution><institution>Emory University, </institution></institution-wrap>Atlanta, GA USA </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0090 6847</institution-id><institution-id institution-id-type="GRID">grid.282356.8</institution-id><institution>Department of Pharmaceutical Sciences, School of Pharmacy, </institution><institution>Philadelphia College of Osteopathic Medicine, </institution></institution-wrap>Georgia Campus, Suwanee, GA USA </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>24</day>
      <month>12</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>24</day>
      <month>12</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2019</year>
    </pub-date>
    <volume>20</volume>
    <issue>Suppl 15</issue>
    <issue-sponsor>Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.</issue-sponsor>
    <elocation-id>489</elocation-id>
    <history>
      <date date-type="received">
        <day>15</day>
        <month>8</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>21</day>
        <month>8</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Â© The Author(s). 2019</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">The biological network is highly dynamic. Functional relations between genes can be activated or deactivated depending on the biological conditions. On the genome-scale network, subnetworks that gain or lose local expression consistency may shed light on the regulatory mechanisms related to the changing biological conditions, such as disease status or tissue developmental stages.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">In this study, we develop a new method to select genes and modules on the existing biological network, in which local expression consistency changes significantly between clinical conditions. The method is called DNLC: Differential Network Local Consistency. In simulations, our algorithm detected artificially created local consistency changes effectively. We applied the method on two publicly available datasets, and the method detected novel genes and network modules that were biologically plausible.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">The new method is effective in finding modules in which the gene expression consistency change between clinical conditions. It is a useful tool that complements traditional differential expression analyses to make discoveries from gene expression data. The R package is available at <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/DNLC">https://cran.r-project.org/web/packages/DNLC</ext-link>.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Biological network</kwd>
      <kwd>Gene expression</kwd>
      <kwd>Local Moranâs I</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id>
            <institution>National Institutes of Health</institution>
          </institution-wrap>
        </funding-source>
        <award-id>R01GM124061</award-id>
        <award-id>R15GM113120</award-id>
        <principal-award-recipient>
          <name>
            <surname>Bai</surname>
            <given-names>Yun</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>Tianwei</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002855</institution-id>
            <institution>Ministry of Science and Technology of the People's Republic of China</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2013CB967101</award-id>
        <principal-award-recipient>
          <name>
            <surname>Lu</surname>
            <given-names>Jianwei</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
            <institution>National Natural Science Foundation of China</institution>
          </institution-wrap>
        </funding-source>
        <award-id>41476120</award-id>
        <award-id>61572362</award-id>
        <award-id>81571347</award-id>
        <award-id>21477087</award-id>
        <principal-award-recipient>
          <name>
            <surname>Lu</surname>
            <given-names>Jianwei</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010098</institution-id>
            <institution>Shanghai Association for Science and Technology</institution>
          </institution-wrap>
        </funding-source>
        <award-id>13PJ1433200</award-id>
        <principal-award-recipient>
          <name>
            <surname>Lu</surname>
            <given-names>Jianwei</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <conference xlink:href="http://alan.cs.gsu.edu/isbra18/">
      <conf-name>14th International Symposium on Bioinformatics Research and Applications (ISBRA'18)</conf-name>
      <conf-acronym>ISBRA 2018</conf-acronym>
      <conf-loc>Beijing, China</conf-loc>
      <conf-date>8-11 June 2018</conf-date>
    </conference>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>Â© The Author(s) 2019</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par12">The biological system operates by tightly controlling the abundance and activity of thousands of proteins. The regulations and interactions can be summarized as a scale-free network [<xref ref-type="bibr" rid="CR1">1</xref>â<xref ref-type="bibr" rid="CR3">3</xref>]. The known networks summarized from existing knowledge, e.g. protein-protein interaction and signal transduction networks, are static in nature. Yet in real biological systems, the activities of the edges on the network are dynamic [<xref ref-type="bibr" rid="CR4">4</xref>]. In the context of gene expression, nodes on the biological network correspond to genes. The expression levels of genes that are close on the network can change between states of correlated, uncorrelated, or even reversely correlated, depending on the biological condition [<xref ref-type="bibr" rid="CR5">5</xref>]. Currently, a number of methods can analyze gene expression data in the context of an existing biological network. Most of the methods try to find ânetwork markersâ, i.e. small subnetworks that change expression levels in response to clinical conditions [<xref ref-type="bibr" rid="CR6">6</xref>â<xref ref-type="bibr" rid="CR17">17</xref>]. Some other methods study the dynamic correlation patterns on the network, without considering the clinical outcome [<xref ref-type="bibr" rid="CR18">18</xref>â<xref ref-type="bibr" rid="CR20">20</xref>].</p>
    <p id="Par13">Given the biological network is dynamic, and physiological conditions influence the activity of the edges in the network, it is natural to consider the change in expression consistency, i.e. the co-expression patterns in subnetworks, in response to changing physiological states. So far, no method is available to find changes of expression consistency on the network. In this manuscript, our goal is to develop a computational method to detect genes around which the expression consistency changes significantly in response to physiological states. Finding such genes can reveal important mechanisms related to disease development, by revealing biological functions that become more tightly regulated or de-regulated in association with disease status. Such a method should be able to complement existing differential expression methods to shed new light on the data.</p>
    <p id="Par14">For this purpose, we borrow the measure of Local Moranâs I (LMI) from the field of spatial statistics, which quantifies spatial auto-correlation on a map [<xref ref-type="bibr" rid="CR21">21</xref>]. We treat the network as a map, and calculate LMI for each node based on its expression value and the expression values of nearby nodes on the network. We then use the LMI values to quantify the local expression consistency around any given node. A high positive LMI value of a node in a specific sample implies that the node has a similar expression value to its neighbors in that sample, and their expression values are either very high or very low. In contrast, a large negative LMI value means the node is a spatial outlier, i.e. a node that has low consistency with its surrounding nodes on the network [<xref ref-type="bibr" rid="CR22">22</xref>]. By combining LMI scores with the clinical data, and using regression models with local false discovery rate correction [<xref ref-type="bibr" rid="CR23">23</xref>], our method finds nodes around which local expression consistency change significantly between different clinical conditions. It showed promising result in both simulations and real data analyses.</p>
  </sec>
  <sec id="Sec2">
    <title>Methods</title>
    <sec id="Sec3">
      <title>Calculating local Moranâs I (LMI) score on the network</title>
      <p id="Par15">The overall workflow of the method is shown in Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>. The data contains four pieces: <bold><italic>M</italic></bold><sub><bold><italic>pâÃâN</italic></bold></sub> is the gene expression matrix with <italic>p</italic> genes in the rows and <italic>N</italic> samples in the columns; <bold><italic>y</italic></bold> is the clinical outcome vector of length <italic>N</italic>; <bold><italic>Gâ=â(V, E)</italic></bold> is the network between the <italic>p</italic> genes, where the vertices <bold><italic>V</italic></bold> correspond to the genes, and the edges <bold><italic>E</italic></bold> represent functional relations between the genes; <bold><italic>C</italic></bold><sub><bold><italic>mâÃâN</italic></bold></sub> is the matrix of other clinical variables, such as age, gender <italic>etc</italic>, with <italic>m</italic> variables in the rows and <italic>N</italic> samples in the columns. We assume there is a one-to-one match between the genes in the matrix and the nodes in the network. Any unmatched genes/nodes are eliminated from the analysis. To prepare for the analysis, the expression matrix is normalized using normal score transformation for every gene.
<fig id="Fig1"><label>Fig. 1</label><caption><p>The overall workflow of our method. <bold>a</bold> The input data structure; <bold>b</bold> Calculating LMI scores for each gene; <bold>c</bold> Finding DC genes</p></caption><graphic xlink:href="12859_2019_3046_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par16">We calculate the LMI score for every gene in each sample. The goal of LMI is to quantify the extent to which nodes that are close to a given node have expression values similar to it. The formula of LMI for gene <italic>i</italic> in sample <italic>k</italic> is:
<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {I}_{i,k}=\frac{z_{i,k}-\overline{z_k}}{\sigma_k^2}{\sum}_{j\ne i}{w}_{ij}\left({z}_{j,k}-\overline{z_k}\right), $$\end{document}</tex-math><mml:math id="M2" display="block"><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>â</mml:mo><mml:mover accent="true"><mml:msub><mml:mi>z</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo stretchy="true">Â¯</mml:mo></mml:mover></mml:mrow><mml:msubsup><mml:mi>Ï</mml:mi><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mfrac><mml:msub><mml:mo>â</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>â </mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>w</mml:mi><mml:mi mathvariant="italic">ij</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>â</mml:mo><mml:mover accent="true"><mml:msub><mml:mi>z</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo stretchy="true">Â¯</mml:mo></mml:mover></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:math><graphic xlink:href="12859_2019_3046_Article_Equa.gif" position="anchor"/></alternatives></disp-formula>where <italic>z</italic><sub><italic>i</italic>, <italic>k</italic></sub> is the expression of gene <italic>i</italic> in sample <italic>k</italic>, <inline-formula id="IEq1"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \overline{z_k} $$\end{document}</tex-math><mml:math id="M4" display="inline"><mml:mover accent="true"><mml:msub><mml:mi>z</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo stretchy="true">Â¯</mml:mo></mml:mover><mml:mspace width="0.25em"/></mml:math><inline-graphic xlink:href="12859_2019_3046_Article_IEq1.gif"/></alternatives></inline-formula> is the average gene expression in sample <italic>k</italic>, <italic>z</italic><sub><italic>j</italic>, <italic>k</italic></sub> is the expression of gene <italic>j</italic> for all the other genes on the network (where <italic>j</italic>ââ â<italic>i</italic>); <inline-formula id="IEq2"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\upsigma}_k^2 $$\end{document}</tex-math><mml:math id="M6" display="inline"><mml:msubsup><mml:mi mathvariant="normal">Ï</mml:mi><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2019_3046_Article_IEq2.gif"/></alternatives></inline-formula> is the variance of expression in sample <italic>k</italic>; <italic>w</italic><sub><italic>ij</italic></sub> is the weight assigned to gene <italic>j</italic>, which depends on its distance to gene <italic>i</italic> on the network.</p>
      <p id="Par17">There can be many strategies for the calculation of weights. The goal is to focus on the small region surrounding gene <italic>i</italic> on the network. One strategy is to assign the inverse of the distance <italic>d</italic><sub><italic>ij</italic></sub> between gene <italic>i</italic> and gene <italic>j</italic> as <italic>w</italic><sub><italic>ij</italic></sub>. Another strategy is to determine <italic>w</italic><sub><italic>ij</italic></sub> using a distance threshold: genes within a distance are given the same weight, while those farther away are given the weight of 0. In this study, we use a truncated Gaussian function to assign the weights,
<disp-formula id="Equb"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {w}_{ij}=\left\{\begin{array}{c}\frac{1}{\sqrt{2\pi }}{e}^{-{d}_{ij}^2/2},{d}_{ij}\le 2\\ {}0,{d}_{ij}&gt;2\end{array}\right., $$\end{document}</tex-math><mml:math id="M8" display="block"><mml:msub><mml:mi>w</mml:mi><mml:mi mathvariant="italic">ij</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfenced close="" open="{"><mml:mtable><mml:mtr><mml:mtd><mml:mfrac><mml:mn>1</mml:mn><mml:msqrt><mml:mrow><mml:mn>2</mml:mn><mml:mi>Ï</mml:mi></mml:mrow></mml:msqrt></mml:mfrac><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>â</mml:mo><mml:msubsup><mml:mi>d</mml:mi><mml:mi mathvariant="italic">ij</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mi mathvariant="italic">ij</mml:mi></mml:msub><mml:mo>â¤</mml:mo><mml:mn>2</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mi mathvariant="italic">ij</mml:mi></mml:msub><mml:mo>&gt;</mml:mo><mml:mn>2</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mfenced><mml:mo>,</mml:mo></mml:math><graphic xlink:href="12859_2019_3046_Article_Equb.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par18">Where <italic>d</italic><sub><italic>ij</italic></sub> is the length of the shortest path between nodes <italic>i</italic> and <italic>j</italic>. The weights are then normalized such that for gene <italic>i</italic>, â<sub><italic>j</italic>ââ â<italic>i</italic></sub><italic>w</italic><sub><italic>ij</italic></sub>â=â1.</p>
      <p id="Par19">The intuition of the approach is as follows: for a given node <italic>i</italic>, only nodes in its vicinity receive substantial weights. Then the calculation of <italic>I</italic><sub><italic>i</italic>, <italic>k</italic></sub> essentially takes a weighted sum of the products of <inline-formula id="IEq3"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \left({z}_{i,k}-\overline{z_k}\right) $$\end{document}</tex-math><mml:math id="M10" display="inline"><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>â</mml:mo><mml:mover accent="true"><mml:msub><mml:mi>z</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo stretchy="true">Â¯</mml:mo></mml:mover></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2019_3046_Article_IEq3.gif"/></alternatives></inline-formula> and all the nodes in the vicinity <inline-formula id="IEq4"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \left({z}_{j,k}-\overline{z_k}\right) $$\end{document}</tex-math><mml:math id="M12" display="inline"><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>â</mml:mo><mml:mover accent="true"><mml:msub><mml:mi>z</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo stretchy="true">Â¯</mml:mo></mml:mover></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2019_3046_Article_IEq4.gif"/></alternatives></inline-formula>, normalized by the variance of the expression levels in the sample. We can see that when <inline-formula id="IEq5"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \left({z}_{i,k}-\overline{z_k}\right) $$\end{document}</tex-math><mml:math id="M14" display="inline"><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>â</mml:mo><mml:mover accent="true"><mml:msub><mml:mi>z</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo stretchy="true">Â¯</mml:mo></mml:mover></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2019_3046_Article_IEq5.gif"/></alternatives></inline-formula> and most of the <inline-formula id="IEq6"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \left({z}_{j,k}-\overline{z_k}\right) $$\end{document}</tex-math><mml:math id="M16" display="inline"><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>â</mml:mo><mml:mover accent="true"><mml:msub><mml:mi>z</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo stretchy="true">Â¯</mml:mo></mml:mover></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2019_3046_Article_IEq6.gif"/></alternatives></inline-formula> are of the same sign, and have large absolute values, <italic>I</italic><sub><italic>i</italic>, <italic>k</italic></sub> will have a large positive value. On the other hand, when <inline-formula id="IEq7"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \left({z}_{i,k}-\overline{z_k}\right) $$\end{document}</tex-math><mml:math id="M18" display="inline"><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>â</mml:mo><mml:mover accent="true"><mml:msub><mml:mi>z</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo stretchy="true">Â¯</mml:mo></mml:mover></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2019_3046_Article_IEq7.gif"/></alternatives></inline-formula> and most of the <inline-formula id="IEq8"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \left({z}_{j,k}-\overline{z_k}\right) $$\end{document}</tex-math><mml:math id="M20" display="inline"><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>â</mml:mo><mml:mover accent="true"><mml:msub><mml:mi>z</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo stretchy="true">Â¯</mml:mo></mml:mover></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2019_3046_Article_IEq8.gif"/></alternatives></inline-formula> are of opposite sign, and have large absolute values, then <italic>I</italic><sub><italic>i</italic>, <italic>k</italic></sub> will be negative with a large absolute value. When there is no expression consistency between the nodes near node <italic>i</italic>, or if their values are close to zero, <italic>I</italic><sub><italic>i</italic>, <italic>k</italic></sub> will be close to zero. Thus the LMI value <italic>I</italic><sub><italic>i</italic>, <italic>k</italic></sub> is a good measure of the expression consistency of node <italic>i</italic> with its network vicinity.</p>
    </sec>
    <sec id="Sec4">
      <title>Selecting differential consistency (DC) genes</title>
      <p id="Par20">After computing <italic>I</italic><sub><italic>i</italic>, <italic>k</italic></sub> for every node <italic>i</italic> in every sample <italic>k</italic>, we have a matrix with the LMI values. The dimension of this LMI matrix is exactly the same as the original gene expression matrix, with <italic>p</italic> genes in the rows and <italic>N</italic> samples in the columns. We then find if a geneâs LMI score changes significantly between different clinical conditions, while incorporating confounders such as age, race etc.</p>
      <p id="Par21">The procedure here is similar to traditional differential expression analysis where confounders are considered (Table <xref rid="Tab1" ref-type="table">1</xref>). The relationship between the clinical outcome, the LMI score of a gene, and confounders can be described by a generalized linear model:
<disp-formula id="Equc"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mathrm{E}\left(\mathrm{y}\ |\mathrm{LMI}\_\mathrm{Score},\mathrm{Confounders}\right)={g}^{-1}\left(\upalpha \times \mathrm{LMI}\_\mathrm{Score}+{\sum}_m{\upbeta}_m\times {\mathrm{Confounder}}_m\right), $$\end{document}</tex-math><mml:math id="M22" display="block"><mml:mi mathvariant="normal">E</mml:mi><mml:mfenced close=")" open="(" separators="|,"><mml:mrow><mml:mi mathvariant="normal">y</mml:mi><mml:mspace width="0.25em"/></mml:mrow><mml:mrow><mml:mi>LMI</mml:mi><mml:mo>_</mml:mo><mml:mtext>Score</mml:mtext></mml:mrow><mml:mtext>Confounders</mml:mtext></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mi>g</mml:mi><mml:mrow><mml:mo>â</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="normal">Î±</mml:mi><mml:mo>Ã</mml:mo><mml:mi>LMI</mml:mi><mml:mo>_</mml:mo><mml:mtext>Score</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mo>â</mml:mo><mml:mi>m</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="normal">Î²</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo>Ã</mml:mo><mml:msub><mml:mtext>Confounder</mml:mtext><mml:mi>m</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:math><graphic xlink:href="12859_2019_3046_Article_Equc.gif" position="anchor"/></alternatives></disp-formula>where <italic>g</italic><sup><italic>â1</italic></sup><italic>(Â·)</italic> is an inverse link function, which can be chosen according to the specific type of the outcome variable. In this study we use the logistic regression for binary outcome variable, and Cox proportional hazards model for survival outcome variable.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>The pseudocode for conducting DC gene search on the network</p></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="2"><p>Input: <bold><italic>G</italic></bold> (gene network), <bold><italic>M</italic></bold> (expression matrix), <bold><italic>y</italic></bold> (clinical outcome vector), <italic>T</italic> (local fdr threshold), <bold><italic>C</italic></bold> (confounder matrix)</p><p>Output: Collection of DC genes: S</p><p>Standardize each row of <bold><italic>M</italic></bold></p><p>Local Moranâs I Matrix <bold><italic>I</italic></bold>â=âLocalâ_âMoranâ_âI(<bold><italic>G</italic></bold>,â<bold><italic>M</italic></bold>)</p><p>For each node <italic>i</italic> in Â <bold><italic>G</italic></bold> do</p><p><italic>t</italic><sub><italic>i</italic></sub>â=âtÂ statistic from generalized linear modelÂ <bold><italic>y</italic></bold>~<bold><italic>I</italic></bold><sub><bold><italic>i</italic></bold></sub>â+â<bold><italic>C</italic></bold></p><p>End for</p><p>Fit {<italic>t</italic><sub><italic>i</italic></sub>}<sub><italic>i</italic>â=â1, â¦, <italic>p</italic></sub> to mixture model using local fdr to find {<italic>lfdr</italic><sub><italic>i</italic></sub>}<sub><italic>i</italic>â=â1, â¦, <italic>p</italic></sub></p><p><italic>S</italic>â=â{<italic>i</italic>â:â<italic>lfdr</italic><sub><italic>i</italic></sub>ââ¤â<italic>T</italic>}</p><p>Return <italic>S</italic></p></td></tr></tbody></table></table-wrap></p>
      <p id="Par22">After the t-statistics for the parameter Î± for all genes are calculated, we follow the local false discovery rate (lfdr) procedure to adjust for multiple testing. For most genes, their local consistency on the network are unrelated to the clinical outcome, and their t-statistics will approximately follow a normal distribution. Genes around which local expression consistency change significantly between clinical conditions will have more extreme t-statistic values. Thus, we can consider the t-statistics of all the genes to follow a mixture model with two components:
<disp-formula id="Equd"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ f(t)={\pi}_0{f}_0(t)+\left(1-{\pi}_0\right){f}_1(t), $$\end{document}</tex-math><mml:math id="M24" display="block"><mml:mi>f</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mi>Ï</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msub><mml:mi>f</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>â</mml:mo><mml:msub><mml:mi>Ï</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo>,</mml:mo></mml:math><graphic xlink:href="12859_2019_3046_Article_Equd.gif" position="anchor"/></alternatives></disp-formula>where <italic>f</italic> is the mixture density for the observed <italic>t</italic>-statistics of all the genes, <italic>f</italic><sub>0</sub> and <italic>f</italic><sub>1</sub> are the densities of the <italic>t</italic>-statistics of the null (non-DC) and non-null (DC) genes respectively, and Ï<sub>0</sub> is the proportion of null genes [<xref ref-type="bibr" rid="CR23">23</xref>]. We can estimate the probability that each gene belongs to the non-null category using mixture density estimation. In this study, we use the R package locfdr for the calculation [<xref ref-type="bibr" rid="CR24">24</xref>]. By setting a threshold for the lfdr value, we can distinguish DC genes from the others.</p>
    </sec>
    <sec id="Sec5">
      <title>Finding network communities of DC genes</title>
      <p id="Par24">After selecting the DC genes, we use a simple and efficient algorithm to group the DC genes and their directly connected genes into network communities for better data interpretation. We adopt the fast-greedy algorithm that directly optimizes modularity score to get the communities of a large graph [<xref ref-type="bibr" rid="CR25">25</xref>]. After detecting several communities among the DC genes and their neighbors, biological function analysis is performed on each detected community. We use the GOstats method [<xref ref-type="bibr" rid="CR26">26</xref>], which is based on the Gene Ontology biological processes, to perform the analysis.</p>
    </sec>
  </sec>
  <sec id="Sec6">
    <title>Results</title>
    <sec id="Sec7">
      <title>Simulation study</title>
      <p id="Par25">We conducted a systematic study using simulated data. In each simulation, data was generated using the following steps.
<list list-type="order"><list-item><p id="Par26">A scale-free network with <italic>m</italic> nodes was generated using the Barabasi-Albert model [<xref ref-type="bibr" rid="CR27">27</xref>]. Based on this network structure, we calculated the <bold><italic>Î£</italic></bold> matrix, in which <italic>Î£</italic><sub><italic>i,j</italic></sub><italic>=</italic>
<inline-formula id="IEq9"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {c}^{d_{i,j}} $$\end{document}</tex-math><mml:math id="M26" display="inline"><mml:msup><mml:mi>c</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:msup></mml:math><inline-graphic xlink:href="12859_2019_3046_Article_IEq9.gif"/></alternatives></inline-formula>, where <italic>c</italic> was a constant between 0 and 1, and d<sub><italic>i</italic>, <italic>j</italic></sub> was the shortest path between nodes <italic>i</italic> and <italic>j</italic> on the network.</p></list-item><list-item><p id="Par27">An <italic>m</italic>âÃâ<italic>n</italic> gene expression matrix was generated using the multivariate normal distribution, using <bold><italic>Î£</italic></bold> as the variance-covariance matrix.</p></list-item><list-item><p id="Par28">We then randomly selected five nodes from the network, the degree of which were within a certain range. Among the nodes within two hops of these five nodes, we changed the elements of the <bold><italic>Î£</italic></bold> matrix to <italic>Î£</italic><sub><italic>i,j</italic></sub><italic>=</italic>
<inline-formula id="IEq10"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {b}^{d_{i,j}} $$\end{document}</tex-math><mml:math id="M28" display="inline"><mml:msup><mml:mi>b</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:msup></mml:math><inline-graphic xlink:href="12859_2019_3046_Article_IEq10.gif"/></alternatives></inline-formula>, where <italic>b</italic> was a constant between 0 and 1, and d<sub><italic>i</italic>, <italic>j</italic></sub> was the shortest path between nodes <italic>i</italic> and <italic>j</italic>.</p></list-item><list-item><p id="Par29">Another <italic>m</italic>âÃâ<italic>n</italic> gene expression data matrix was generated using the multivariate normal density, using the modified <bold><italic>Î£</italic></bold> matrix as the variance-covariance matrix.</p></list-item><list-item><p id="Par30">We joined the two matrixes horizontally to obtain the simulated expression matrix, which was of dimension <italic>m</italic>âÃâ2<italic>n</italic>, where <italic>m</italic> was the number of genes and 2<italic>n</italic> was the total number of samples.</p></list-item><list-item><p id="Par31">The outcome variable corresponding to first <italic>n</italic> samples (original correlation samples) were set to 0, and the last <italic>n</italic> samples (changed correlation samples) were set to 1.</p></list-item></list></p>
      <p id="Par32">Four parameters were used to control the signal strength of the data: (a) The base correlation <italic>c</italic>, which controlled the background correlation strength. Four levels were used (base correlationâ=â0.2, 0.4, 0.6, 0.8). (b) The changed correlation <italic>b</italic>. We applied four levels (changed correlationâ=â0.2, 0.4, 0.6, 0.8) for simulation. (c) The degrees of the five selected nodes. Two ranges (degrees between 5 to 10, and between 15 to 20) were used. (d) Sample size in the simulated expression data (number of samplesâ=â50, 100, 200, 300, 400, 500, 700, 1000).</p>
      <p id="Par33">Fifty datasets were simulated at each parameter setting. After a dataset was generated, we used three methods to analyze the data: (1) the DNLC algorithm; (2) the differential network analysis (DNA) method [<xref ref-type="bibr" rid="CR28">28</xref>], and (3) simple differential expression (DE) analysis using t-test and local fdr correction. We evaluated the results by the PR-AUC (area under the precision-recall curve). Each node was assigned a status depending on the generation process: 1 (changed correlation with neighbors) or 0 (unchanged correlation with neighbors). The local fdr values calculated by each method were used as the predictor variable to generate the precision-recall curve. In each setting, the average area under the curve (AUC) was calculated to reflect the efficacy that the nodes with true local expression consistency changes were differentiated from other nodes.</p>
      <p id="Par34">As shown in Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>, when the base correlation level <italic>c</italic> was equal to the changed correlation level <italic>b</italic>, at all settings the PR-AUC values were close to zero (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). On the other hand, when the base correlation level <italic>c</italic> was different from the changed correlation level <italic>b</italic>, the PR-AUC values increased with the sample size, both in the cases of <italic>b</italic>â&gt;â<italic>c</italic> and in the cases of <italic>b</italic>â&lt;â<italic>c</italic>. When the base correlation <italic>c</italic> was high (0.6 or 0.8), the power to detect the DC nodes was limited (Fig. <xref rid="Fig2" ref-type="fig">2</xref>, second and fourth columns). On the other hand, when the base correlation was at low or medium level (0.2 or 0.4), which was close to real data situations, the power was reasonably high when the difference between <italic>b</italic> and <italic>c</italic> was high (Fig. <xref rid="Fig2" ref-type="fig">2</xref>, first and third columns). In comparison, testing for differential expression didnât detect the differential consistency on the network in most cases. The differential network analysis (DNA) method exhibited some power to detect network differential local consistency, but its AUC values were lower than the DNLC method in most cases, except when the base correlation was high, and the network density was high (Fig. <xref rid="Fig2" ref-type="fig">2</xref>, lower-right panel). Although the DNA method seeks differential correlation, it doesnât use network information, which was likely the reason of the inferior performance. Overall, the simulation results validated that the DNLC method was effective in separating the nodes around which the expression consistency were changed.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Simulation results. The PR-AUC are plotted against the sample sizes. Each data point represents the average result of 50 simulations</p></caption><graphic xlink:href="12859_2019_3046_Fig2_HTML" id="MO2"/></fig></p>
    </sec>
    <sec id="Sec8">
      <title>Real data analysis: GSE10255</title>
      <p id="Par35">To test our method, we used the High-quality Interaction (HINT) database [<xref ref-type="bibr" rid="CR29">29</xref>] for the human biological network. Two publicly available expression datasets were analyzed. The first dataset was the gene expression dataset of acute lymphoblastic leukemia (ALL) subjects in response to methotrexate (MTX) treatment (GSE10255) [<xref ref-type="bibr" rid="CR30">30</xref>]. The dataset contained 12,704 rows (genes) and 161 columns (samples). The clinical outcome variable was the reduction of circulating leukemia cells after MTX treatment. At the lfdr threshold of 0.2, a total of 510âDC genes were selected. Furthermore, network modules were detected among the selected genes and their immediate neighbors on the network. In the following discussion, we focus on the largest module. The plots and functional annotations of all the modules are available at <ext-link ext-link-type="uri" xlink:href="http://web1.sph.emory.edu">web1.sph.emory.edu</ext-link>/users/tyu8/DNLC/MTX.</p>
      <p id="Par36">We used the GOStats package to find gene ontology terms that were over-represented by the lists of genes [<xref ref-type="bibr" rid="CR26">26</xref>]. For the largest network module (Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>a), the biological processes overrepresented by the positive DC genes, i.e. genes with increased local consistency in patients with higher MTX response, could be categorized into five major groups: phosphorylation and ubiquitination; peptide hormone secretion; catabolic process; DNA synthetic and repairing; apoptosis and response to hyperoxia. All these functions are closely related to MTX sensitivity in ALL. It has been well-documented that genes that regulate protein modification, apoptosis and DNA synthesis/repair influence caner development [<xref ref-type="bibr" rid="CR31">31</xref>]. Both phosphorylation and ubiquitination of proteins have been reported to play important roles in MTX resistance in leukemia treatment. Phosphorylation of HSC70, an MTX-binding protein, regulates the transportation of MTX into the cells and contributes to MTX resistance in L1210 leukemia cells [<xref ref-type="bibr" rid="CR32">32</xref>]. It has also been demonstrated that the MTX chemotherapeutic effect can be significantly reduced by antiepileptic drugs due to the downregulation of reduced folate carrier (Rfc1) activity, regulated by the ubiquitin-proteasome pathway [<xref ref-type="bibr" rid="CR33">33</xref>]. Among the selected genes by our method, genes 868 (CBLB), 5705 (PSMC5) and 5717 (PSMD11) regulate protein modifications. Many research demonstrated the role of CBLB in leukemia [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>], while PSMC5 and PSMD11 were only reported to be involved in cancer development in very recent studies [<xref ref-type="bibr" rid="CR36">36</xref>â<xref ref-type="bibr" rid="CR38">38</xref>].
<fig id="Fig3"><label>Fig. 3</label><caption><p>The first module from the GSE10255 dataset. <bold>a</bold> genes with LMI positively associated with MTX response (red); <bold>b</bold> genes with LMI negatively associated with MTX response (blue). Entrez gene IDs are used in the plots</p></caption><graphic xlink:href="12859_2019_3046_Fig3_HTML" id="MO3"/></fig></p>
      <p id="Par37">We next focus on the genes that regulate hormone secretion [<xref ref-type="bibr" rid="CR39">39</xref>], catabolic process [<xref ref-type="bibr" rid="CR40">40</xref>], and hyperoxia [<xref ref-type="bibr" rid="CR41">41</xref>], whose roles in ALL treatment are not self-evident. The genes that regulate peptide/protein secretion interfere with the efficacy of chemotherapy to cancer cells by regulating hormone levels. It has been reported that the secretion of peptide hormones are changed in ALL [<xref ref-type="bibr" rid="CR42">42</xref>]. In addition, some papers reported that insulin and insulin-like factor (IGF) secretions affect the resistance of chemotherapy in ALL patients [<xref ref-type="bibr" rid="CR43">43</xref>]. Among the selected genes, genes 640 (BLK proto-oncogene), 3717 (JAK2), 8660 (IRS2) and 25,924 (MYRIP) are major genes involved in peptide secretions. JAK2 mutation is believed to have prognostic impact in acute myeloid leukemia [<xref ref-type="bibr" rid="CR44">44</xref>â<xref ref-type="bibr" rid="CR46">46</xref>]. The BLK proto-oncogene is involved in leukemia development [<xref ref-type="bibr" rid="CR47">47</xref>]. IRS2 is an adaptor protein associated with the receptor of erythropoietin, insulin-like growth factor 1. Defective IRS2 expression plays a role in impaired hematopoietic cell differentiation [<xref ref-type="bibr" rid="CR48">48</xref>] .</p>
      <p id="Par38">The selected DC genes also included genes that regulate protein catabolic process. It has been reported that resistance to methotrexate (MTX) in leukemia is related to hydrolase and thymidylate synthase activities, which are catabolic processes [<xref ref-type="bibr" rid="CR49">49</xref>]. Among the selected genes, 2308 (FOXO1) and 5707 (PSMD1) are regulators of the catabolic process. It has been reported that FOXO1 can play a role in the development of acute myeloid leukemia (AML) [<xref ref-type="bibr" rid="CR50">50</xref>]. Currently, there are no report about the relationship between PSMD1 and leukemia. However, PSMD1 has been reported to be overexpressed in other cancers [<xref ref-type="bibr" rid="CR51">51</xref>].</p>
      <p id="Par39">The negative DC genes, i.e. genes with decreased local consistency in patients with higher MTX response (Fig. <xref rid="Fig3" ref-type="fig">3</xref>b), were also clearly related to cancer development and progressions. The over-represented GO terms by the negative DC genes include immune cell development and activation [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]; apoptosis [<xref ref-type="bibr" rid="CR54">54</xref>]; mammary gland epithelium cell proliferation [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]; cell-cell adhesion [<xref ref-type="bibr" rid="CR57">57</xref>], and cell depolymerization [<xref ref-type="bibr" rid="CR58">58</xref>]. A number of the selected DC genes are known to affect ALL progression. Also, some of them are known to regulate MTX resistance in leukemia treatment. For example, our method selected genes 595 (CCND1) and 3398 (ID2) that regulate mammary gland epithelial cell proliferation. It has been reported that CCND1 G870A polymorphism is associated with the risk of leukemia and toxicity of MTX in ALL [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. ID2 is known to be associated with chemotherapy response and prognosis in acute myeloid leukemia [<xref ref-type="bibr" rid="CR61">61</xref>].</p>
    </sec>
    <sec id="Sec9">
      <title>Real data analysis: TCGA BRCA dataset</title>
      <p id="Par40">We applied the method to a second data set, the breast cancer (BRCA) gene expression dataset from The Cancer Genome Atlas (TCGA). We used the Cox proportional hazards model to link gene LMI values with patient survival outcome, while adjusting for baseline demographic variables including age, gender, and ethnicity. The plots and functional annotations of all the modules are at <ext-link ext-link-type="uri" xlink:href="http://web1.sph.emory.edu">web1.sph.emory.edu</ext-link>/users/tyu8/DNLC/BRCA. Again we focus on the largest modules for the discussion here.</p>
      <p id="Par41">In the first module (Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>a), the negative DC genes, i.e. genes with decreased local consistency in patients with lower risk, appear to be more functionally coherent. The biological processes over-represented by the negative DC genes include protein/peptide metabolic process, biogenesis, or membrane targeting and transport, which are obviously related to breast cancer development. As examples, genes 6125 (RPL5) and 6138 (RPL15) were among the most significant genes in the list. RPL5 has been reported to be a tumor suppressor gene in breast cancer development [<xref ref-type="bibr" rid="CR62">62</xref>]. While there is no research paper reporting the role of RPL15 in breast cancer, one study suggested the methylation of RPL15 may be involved in cancer development [<xref ref-type="bibr" rid="CR63">63</xref>]. Genes 333 (APLP1), 476 (ATP1A1), 1113 (CHGA), and 2026 (ENO2) were on the positive gene list. ATP1A1 has been previously reported to be over-expressed in breast cancer [<xref ref-type="bibr" rid="CR64">64</xref>]. The overexpression CHGA, a neuroendocrine carcinomas marker, characterizes 10% of infiltrative breast cancer [<xref ref-type="bibr" rid="CR65">65</xref>]. ENO2 is used as a biomarker to help identify neuroendocrine differentiation in breast cancer [<xref ref-type="bibr" rid="CR66">66</xref>].
<fig id="Fig4"><label>Fig. 4</label><caption><p>The first two modules from TCGA BRCA data. <bold>a</bold> module 1; <bold>b</bold> module 2. Red: LMI positively associated with survival; blue: LMI negatively associated with survival. Entrez gene IDs are used in the plots</p></caption><graphic xlink:href="12859_2019_3046_Fig4_HTML" id="MO4"/></fig></p>
      <p id="Par42">In module 2 (Fig. <xref rid="Fig4" ref-type="fig">4</xref>b), the majority of the positive genes were involved in protein ubiquitination, which is a critical process in cancer development [<xref ref-type="bibr" rid="CR67">67</xref>]. Functional groups of the negative genes include I-Kappa B kinase signaling. Nuclear factor kappa-beta (NF-kappaB) is a transcription factor that modulates the expression of many genes involved in cell proliferation, differentiation, apoptosis and metastasis. Nuclear factor-kappa B is used as a predictor of treatment response in breast cancer [<xref ref-type="bibr" rid="CR68">68</xref>]. Expression of nuclear factor kappa B (NF-ÎºB) is also used as a predictor of pathologic response to chemotherapy in patients with locally advanced breast cancer [<xref ref-type="bibr" rid="CR69">69</xref>]. In the I-Kappa B kinase signaling pathway, our method found genes 4792 (NFKBIA), 23,476 (BRD4), and 79,155 (TNIP2) to be significantly associated with breast cancer survival. One study investigated common variants within the gene coding region for NF-kappaB and IkappaB, NFKB1 and NFKBIA, for involvement in sporadic breast cancer. However, the results did not support an involvement of the NFKBIA polymorphisms in sporadic breast cancer in the Caucasian population [<xref ref-type="bibr" rid="CR70">70</xref>].</p>
      <p id="Par43">The local consistencies of genes 3636 (INPPL1) and 5027 (P2RX7) were also found to be negatively associated to breast cancer survival. They regulate phospholipid dephosphorylation and transport. INPPL1 is also known as SHIP2, which is involved in breast cancer development [<xref ref-type="bibr" rid="CR71">71</xref>â<xref ref-type="bibr" rid="CR73">73</xref>]. P2RX7 is also known as P2X7. Purinergic signaling has been implicated in the regulation of many cellular processes and is involved in tumor development and metastasis. Reports revealed that the activation of the P2X7 receptor promotes breast cancer cell invasion and migration, and the P2X7 receptor may be a useful therapeutic target for the treatment of breast cancer [<xref ref-type="bibr" rid="CR74">74</xref>].</p>
    </sec>
  </sec>
  <sec id="Sec10">
    <title>Discussions</title>
    <p id="Par44">In this manuscript, we presented a new method to detect differential consistency (DC) genes on the biological network, as well as network modules where DC genes are concentrated. By using the Local Moranâs I (LMI) for measuring local expression consistency on the network, and using the regression framework, the method is versatile enough to be able to study continuous, categorical, and survival outcomes.</p>
    <p id="Par45">Given a large-scale network containing thousands of nodes, the number of possible sub-networks is astronomical. Thus we take the approach of focusing on a specific type of subnetwork: the ego-network, which is defined by the neighborhood of a given node [<xref ref-type="bibr" rid="CR11">11</xref>]. This approach reduces the number of sub-networks to the number of nodes in the network. The algorithm focuses on the relations between the center node of each subnetwork to its surrounding nodes, using the LMI to measure their expression consistency. The computing time of the method increases roughly linearly with the number of genes (nodes) and the sample size (Fig.Â <xref rid="Fig5" ref-type="fig">5</xref>). For example, with 10,000 genes and 500 samples, the method costs roug hly 12âmin using single thread computation.
<fig id="Fig5"><label>Fig. 5</label><caption><p>The computing time of the DNLC method. The computing time was recorded on a Lenovo Think Station P9000 with Xeon E5â2630 CPU, using a single thread for computing</p></caption><graphic xlink:href="12859_2019_3046_Fig5_HTML" id="MO5"/></fig></p>
  </sec>
  <sec id="Sec11">
    <title>Conclusion</title>
    <p id="Par46">In simulations and real data analyses, we have shown the method is effective in finding genes around which expression consistency changes in response to the clinical outcome. The method is a useful tool that complements traditional differential expression type of analyses to make discoveries from gene expression data.</p>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>ALL</term>
        <def>
          <p id="Par4">Acute lymphoblastic leukemia</p>
        </def>
      </def-item>
      <def-item>
        <term>BRCA</term>
        <def>
          <p id="Par5">Breast invasive carcinoma cohort</p>
        </def>
      </def-item>
      <def-item>
        <term>DC</term>
        <def>
          <p id="Par6">Differential Consistency</p>
        </def>
      </def-item>
      <def-item>
        <term>HINT</term>
        <def>
          <p id="Par7">High-quality Interaction database</p>
        </def>
      </def-item>
      <def-item>
        <term>lfdr</term>
        <def>
          <p id="Par8">local false discovery rate</p>
        </def>
      </def-item>
      <def-item>
        <term>LMI</term>
        <def>
          <p id="Par9">Local Moranâs I</p>
        </def>
      </def-item>
      <def-item>
        <term>PR-AUC</term>
        <def>
          <p id="Par10">Area under the precision-recall curve</p>
        </def>
      </def-item>
      <def-item>
        <term>TCGA</term>
        <def>
          <p id="Par11">The Cancer Genome Atlas</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisherâs Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
    <fn>
      <p>Jianwei Lu, Yao Lu and Yusheng Ding contributed equally to this work.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>The authors thank Dr. Hao Wu and Dr. Steve Qin for helpful discussions.</p>
    <sec id="FPar1">
      <title>About this supplement</title>
      <p id="Par47">This article has been published as part of BMC Bioinformatics, Volume 20 Supplement 15, 2019: Selected articles from the 14th International Symposium on Bioinformatics Research and Applications (ISBRA-18): bioinformatics. The full contents of the supplement are available at https://bmcbioinformatics.biomedcentral.com/articles/supplements/volume-20-supplement-15.</p>
    </sec>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authorsâ contributions</title>
    <p>TY and YB conceived the study. QX and TY designed the algorithm. YL, YD, and LL programed the R package. JL, YL, YD, QC and YK conducted data processing. YB conducted results interpretation. YL, YD, YB and TY drafted the manuscript. All authors have read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work was partially supported by NIH grants R01GM124061 and R15GM113120, Ministry of Science and Technology of China 973 Program grant No. 2013CB967101, Natural Science Foundation of China grants No. 41476120, No. 61572362, No. 81571347 and No. 21477087, and Shanghai Science Committee Foundation Grant No. 13PJ1433200. Publication costs are funded by NIH grant R01GM124061.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The R package is available at <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/DNLC">https://cran.r-project.org/web/packages/DNLC</ext-link>.</p>
  </notes>
  <notes>
    <title>Ethics approval and consent to participate</title>
    <p id="Par48">Not applicable.</p>
  </notes>
  <notes>
    <title>Consent for publication</title>
    <p id="Par49">Not applicable.</p>
  </notes>
  <notes notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par50">The authors declare that they have no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>BarabÃ¡si</surname>
            <given-names>A-L</given-names>
          </name>
        </person-group>
        <article-title>Network medicine--from obesity to the âdiseasomeâ</article-title>
        <source>N Engl J Med</source>
        <year>2007</year>
        <volume>357</volume>
        <fpage>404</fpage>
        <lpage>407</lpage>
        <pub-id pub-id-type="doi">10.1056/NEJMe078114</pub-id>
        <?supplied-pmid 17652657?>
        <pub-id pub-id-type="pmid">17652657</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>BarabÃ¡si</surname>
            <given-names>A-L</given-names>
          </name>
          <name>
            <surname>Gulbahce</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Loscalzo</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Network medicine: a network-based approach to human disease</article-title>
        <source>Nat Rev Genet</source>
        <year>2011</year>
        <volume>12</volume>
        <fpage>56</fpage>
        <lpage>68</lpage>
        <pub-id pub-id-type="doi">10.1038/nrg2918</pub-id>
        <?supplied-pmid 3140052?>
        <pub-id pub-id-type="pmid">21164525</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chan</surname>
            <given-names>SY</given-names>
          </name>
          <name>
            <surname>Loscalzo</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>The emerging paradigm of network medicine in the study of human disease</article-title>
        <source>Circ Res</source>
        <year>2012</year>
        <volume>111</volume>
        <fpage>359</fpage>
        <lpage>374</lpage>
        <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.258541</pub-id>
        <?supplied-pmid 22821909?>
        <pub-id pub-id-type="pmid">22821909</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ideker</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Krogan</surname>
            <given-names>NJ</given-names>
          </name>
        </person-group>
        <article-title>Differential network biology</article-title>
        <source>Mol Syst Biol</source>
        <year>2012</year>
        <volume>8</volume>
        <fpage>565</fpage>
        <pub-id pub-id-type="doi">10.1038/msb.2011.99</pub-id>
        <?supplied-pmid 22252388?>
        <pub-id pub-id-type="pmid">22252388</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>A new dynamic correlation algorithm reveals novel functional aspects in single cell and bulk RNA-seq data</article-title>
        <source>PLoS Comput Biol</source>
        <year>2018</year>
        <volume>14</volume>
        <issue>8</issue>
        <fpage>e1006391</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.1006391</pub-id>
        <?supplied-pmid 30080856?>
        <pub-id pub-id-type="pmid">30080856</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Xuan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Riggins</surname>
            <given-names>RB</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Clarke</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Identifying protein interaction subnetworks by a bagging Markov random field-based method</article-title>
        <source>Nucleic Acids Res</source>
        <year>2013</year>
        <volume>41</volume>
        <fpage>e42</fpage>
        <pub-id pub-id-type="doi">10.1093/nar/gks951</pub-id>
        <?supplied-pmid 23161673?>
        <pub-id pub-id-type="pmid">23161673</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ciriello</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Cerami</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Sander</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Schultz</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Mutual exclusivity analysis identifies oncogenic network modules</article-title>
        <source>Genome Res</source>
        <year>2012</year>
        <volume>22</volume>
        <fpage>398</fpage>
        <lpage>406</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.125567.111</pub-id>
        <?supplied-pmid 21908773?>
        <pub-id pub-id-type="pmid">21908773</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nie</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Mining breast cancer genes with a network based noise-tolerant approach</article-title>
        <source>BMC Syst Biol</source>
        <year>2013</year>
        <volume>7</volume>
        <fpage>49</fpage>
        <pub-id pub-id-type="doi">10.1186/1752-0509-7-49</pub-id>
        <?supplied-pmid 23799982?>
        <pub-id pub-id-type="pmid">23799982</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Su</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yoon</surname>
            <given-names>B-J</given-names>
          </name>
          <name>
            <surname>Dougherty</surname>
            <given-names>ER</given-names>
          </name>
        </person-group>
        <article-title>Identification of diagnostic subnetwork markers for cancer in human protein-protein interaction network</article-title>
        <source>BMC Bioinf</source>
        <year>2010</year>
        <volume>11</volume>
        <issue>Suppl 6</issue>
        <fpage>S8</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-11-S6-S8</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Taylor</surname>
            <given-names>IW</given-names>
          </name>
          <name>
            <surname>Linding</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Warde-Farley</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Pesquita</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Faria</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Bull</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pawson</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Morris</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Wrana</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>Dynamic modularity in protein interaction networks predicts breast cancer outcome</article-title>
        <source>Nat Biotechnol</source>
        <year>2009</year>
        <volume>27</volume>
        <fpage>199</fpage>
        <lpage>204</lpage>
        <pub-id pub-id-type="doi">10.1038/nbt.1522</pub-id>
        <?supplied-pmid 19182785?>
        <pub-id pub-id-type="pmid">19182785</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bai</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Qin</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>EgoNet: identification of human disease ego-network modules</article-title>
        <source>BMC Genomics</source>
        <year>2014</year>
        <volume>15</volume>
        <fpage>314</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2164-15-314</pub-id>
        <?supplied-pmid 24773628?>
        <pub-id pub-id-type="pmid">24773628</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>YZ</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>TW</given-names>
          </name>
        </person-group>
        <article-title>A Bayesian nonparametric mixture model for selecting genes and gene subnetworks</article-title>
        <source>Ann Appl Stat</source>
        <year>2014</year>
        <volume>8</volume>
        <issue>2</issue>
        <fpage>999</fpage>
        <lpage>1021</lpage>
        <pub-id pub-id-type="doi">10.1214/14-AOAS719</pub-id>
        <?supplied-pmid 25984253?>
        <pub-id pub-id-type="pmid">25984253</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sanguinetti</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Noirel</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wright</surname>
            <given-names>PC</given-names>
          </name>
        </person-group>
        <article-title>MMG: a probabilistic tool to identify submodules of metabolic pathways</article-title>
        <source>Bioinformatics</source>
        <year>2008</year>
        <volume>24</volume>
        <issue>8</issue>
        <fpage>1078</fpage>
        <lpage>1084</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btn066</pub-id>
        <?supplied-pmid 18292114?>
        <pub-id pub-id-type="pmid">18292114</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wei</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Network-based genomic discovery: application and comparison of Markov random field models</article-title>
        <source>J R Stat Soc: Ser C: Appl Stat</source>
        <year>2010</year>
        <volume>59</volume>
        <issue>1</issue>
        <fpage>105</fpage>
        <lpage>125</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1467-9876.2009.00686.x</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wei</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Bayesian joint modeling of multiple gene networks and diverse genomic data to identify target genes of a transcription factor</article-title>
        <source>Ann Appl Stat</source>
        <year>2012</year>
        <volume>6</volume>
        <issue>1</issue>
        <fpage>334</fpage>
        <lpage>355</lpage>
        <pub-id pub-id-type="doi">10.1214/11-AOAS502</pub-id>
        <?supplied-pmid 22408712?>
        <pub-id pub-id-type="pmid">22408712</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Bayesian network feature finder (BANFF): an R package for gene network feature selection</article-title>
        <source>Bioinformatics</source>
        <year>2016</year>
        <volume>32</volume>
        <issue>23</issue>
        <fpage>3685</fpage>
        <lpage>3687</lpage>
        <?supplied-pmid 27503223?>
        <pub-id pub-id-type="pmid">27503223</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cai</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Alvarez</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Network marker selection for untargeted LC-MS metabolomics data</article-title>
        <source>J Proteome Res</source>
        <year>2017</year>
        <volume>16</volume>
        <issue>3</issue>
        <fpage>1261</fpage>
        <lpage>1269</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jproteome.6b00861</pub-id>
        <?supplied-pmid 28168878?>
        <pub-id pub-id-type="pmid">28168878</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Qiu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gong</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bai</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Detecting subnetwork-level dynamic correlations</article-title>
        <source>Bioinformatics</source>
        <year>2017</year>
        <volume>33</volume>
        <issue>2</issue>
        <fpage>256</fpage>
        <lpage>265</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btw616</pub-id>
        <?supplied-pmid 27667792?>
        <pub-id pub-id-type="pmid">27667792</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Ho</surname>
            <given-names>YY</given-names>
          </name>
          <name>
            <surname>Tseng</surname>
            <given-names>GC</given-names>
          </name>
        </person-group>
        <article-title>Meta-analytic framework for liquid association</article-title>
        <source>Bioinformatics</source>
        <year>2017</year>
        <volume>33</volume>
        <fpage>2140</fpage>
        <lpage>2147</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btx138</pub-id>
        <?supplied-pmid 28334340?>
        <pub-id pub-id-type="pmid">28334340</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ho</surname>
            <given-names>YY</given-names>
          </name>
          <name>
            <surname>Parmigiani</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Louis</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Cope</surname>
            <given-names>LM</given-names>
          </name>
        </person-group>
        <article-title>Modeling liquid association</article-title>
        <source>Biometrics</source>
        <year>2011</year>
        <volume>67</volume>
        <issue>1</issue>
        <fpage>133</fpage>
        <lpage>141</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1541-0420.2010.01440.x</pub-id>
        <?supplied-pmid 20528865?>
        <pub-id pub-id-type="pmid">20528865</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Anselin</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Local indicators of spatial associationâLISA</article-title>
        <source>Geogr Anal</source>
        <year>1995</year>
        <volume>27</volume>
        <issue>2</issue>
        <fpage>93</fpage>
        <lpage>115</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1538-4632.1995.tb00338.x</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lalor</surname>
            <given-names>GC</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Multivariate outlier detection and remediation in geochemical databases</article-title>
        <source>Sci Total Environ</source>
        <year>2001</year>
        <volume>281</volume>
        <issue>1</issue>
        <fpage>99</fpage>
        <lpage>109</lpage>
        <pub-id pub-id-type="doi">10.1016/S0048-9697(01)00839-7</pub-id>
        <?supplied-pmid 11778964?>
        <pub-id pub-id-type="pmid">11778964</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Efron</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Tibshirani</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Empirical Bayes methods and false discovery rates for microarrays</article-title>
        <source>Genet Epidemiol</source>
        <year>2002</year>
        <volume>23</volume>
        <issue>1</issue>
        <fpage>70</fpage>
        <lpage>86</lpage>
        <pub-id pub-id-type="doi">10.1002/gepi.1124</pub-id>
        <?supplied-pmid 12112249?>
        <pub-id pub-id-type="pmid">12112249</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Efron</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Turnbull</surname>
            <given-names>BB</given-names>
          </name>
          <name>
            <surname>Narasimhan</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>locfdr: Computes local false discovery rates</article-title>
        <source>R Package</source>
        <year>2011</year>
        <volume>1</volume>
        <fpage>1</fpage>
        <lpage>7</lpage>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Clauset</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Newman</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Moore</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Finding community structure in very large networks</article-title>
        <source>Phys Rev E</source>
        <year>2004</year>
        <volume>70</volume>
        <issue>6</issue>
        <fpage>066111</fpage>
        <pub-id pub-id-type="doi">10.1103/PhysRevE.70.066111</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Falcon</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gentleman</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Using GOstats to test gene lists for GO term association</article-title>
        <source>Bioinformatics</source>
        <year>2007</year>
        <volume>23</volume>
        <issue>2</issue>
        <fpage>257</fpage>
        <lpage>258</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btl567</pub-id>
        <?supplied-pmid 17098774?>
        <pub-id pub-id-type="pmid">17098774</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>BarabÃ¡si</surname>
            <given-names>A-L</given-names>
          </name>
          <name>
            <surname>Albert</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Emergence of scaling in random networks</article-title>
        <source>Science</source>
        <year>1999</year>
        <volume>286</volume>
        <issue>5439</issue>
        <fpage>509</fpage>
        <lpage>512</lpage>
        <pub-id pub-id-type="doi">10.1126/science.286.5439.509</pub-id>
        <?supplied-pmid 10521342?>
        <pub-id pub-id-type="pmid">10521342</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gill</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Datta</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Datta</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>A statistical framework for differential network analysis from microarray data</article-title>
        <source>BMC Bioinf</source>
        <year>2010</year>
        <volume>11</volume>
        <fpage>95</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-11-95</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Das</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>HINT: high-quality protein interactomes and their applications in understanding human disease</article-title>
        <source>BMC Syst Biol</source>
        <year>2012</year>
        <volume>6</volume>
        <fpage>92</fpage>
        <pub-id pub-id-type="doi">10.1186/1752-0509-6-92</pub-id>
        <?supplied-pmid 22846459?>
        <pub-id pub-id-type="pmid">22846459</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sorich</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Pottier</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Pei</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Kager</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Stocco</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Panetta</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Pui</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Relling</surname>
            <given-names>MV</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile</article-title>
        <source>PLoS Med</source>
        <year>2008</year>
        <volume>5</volume>
        <issue>4</issue>
        <fpage>e83</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pmed.0050083</pub-id>
        <?supplied-pmid 18416598?>
        <pub-id pub-id-type="pmid">18416598</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Saeki</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Masahito</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Apoptosis of B lymphocytic leukemia induced by anticancer drugs and their cell cycle specificity</article-title>
        <source>Zhonghua Zhong Liu Za Zhi</source>
        <year>1998</year>
        <volume>20</volume>
        <issue>1</issue>
        <fpage>25</fpage>
        <lpage>27</lpage>
        <?supplied-pmid 10921050?>
        <pub-id pub-id-type="pmid">10921050</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Rios</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Bhushan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sheridan</surname>
            <given-names>PP</given-names>
          </name>
          <name>
            <surname>Bearden</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Lai</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Agbenowu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Cao</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Tyrosine phosphorylation of HSC70 and its interaction with RFC mediates methotrexate resistance in murine L1210 leukemia cells</article-title>
        <source>Cancer Lett</source>
        <year>2015</year>
        <volume>357</volume>
        <issue>1</issue>
        <fpage>231</fpage>
        <lpage>241</lpage>
        <pub-id pub-id-type="doi">10.1016/j.canlet.2014.11.036</pub-id>
        <?supplied-pmid 25444929?>
        <pub-id pub-id-type="pmid">25444929</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Halwachs</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Schaefer</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Seibel</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Honscha</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Antiepileptic drugs reduce the efficacy of methotrexate chemotherapy through accelerated degradation of the reduced folate carrier by the ubiquitin-proteasome pathway</article-title>
        <source>Chemotherapy</source>
        <year>2011</year>
        <volume>57</volume>
        <issue>4</issue>
        <fpage>345</fpage>
        <lpage>356</lpage>
        <pub-id pub-id-type="doi">10.1159/000330461</pub-id>
        <?supplied-pmid 21912117?>
        <pub-id pub-id-type="pmid">21912117</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Caligiuri</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Briesewitz</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Arnoczky</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Marburger</surname>
            <given-names>TB</given-names>
          </name>
          <name>
            <surname>Wen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Perrotti</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Bloomfield</surname>
            <given-names>CD</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia</article-title>
        <source>Blood</source>
        <year>2007</year>
        <volume>110</volume>
        <issue>3</issue>
        <fpage>1022</fpage>
        <lpage>1024</lpage>
        <pub-id pub-id-type="doi">10.1182/blood-2006-12-061176</pub-id>
        <?supplied-pmid 17475912?>
        <pub-id pub-id-type="pmid">17475912</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Qu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Hou</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Cbl-b promotes chemotherapy-induced apoptosis in rat basophilic leukemia cells by suppressing PI3K/Akt activation and enhancing MEK/ERK activation</article-title>
        <source>Mol Cell Biochem</source>
        <year>2010</year>
        <volume>340</volume>
        <issue>1â2</issue>
        <fpage>107</fpage>
        <lpage>114</lpage>
        <pub-id pub-id-type="doi">10.1007/s11010-010-0407-8</pub-id>
        <?supplied-pmid 20177738?>
        <pub-id pub-id-type="pmid">20177738</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jhaveri</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>ED</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Klein</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Le</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Laheru</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Pandey</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Using quantitative Seroproteomics to identify antibody biomarkers in pancreatic Cancer</article-title>
        <source>Cancer Immunol Res</source>
        <year>2016</year>
        <volume>4</volume>
        <issue>3</issue>
        <fpage>225</fpage>
        <lpage>233</lpage>
        <pub-id pub-id-type="doi">10.1158/2326-6066.CIR-15-0200-T</pub-id>
        <?supplied-pmid 26842750?>
        <pub-id pub-id-type="pmid">26842750</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yim</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Yun</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Baek</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>JY</given-names>
          </name>
          <name>
            <surname>Um</surname>
            <given-names>HD</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>IC</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Radiosensitizing effect of PSMC5, a 19S proteasome ATPase, in H460 lung cancer cells</article-title>
        <source>Biochem Biophys Res Commun</source>
        <year>2016</year>
        <volume>469</volume>
        <issue>1</issue>
        <fpage>94</fpage>
        <lpage>100</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bbrc.2015.11.077</pub-id>
        <?supplied-pmid 26592665?>
        <pub-id pub-id-type="pmid">26592665</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Qi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Luan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kong</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Proteomic profiling identified multiple short-lived members of the central proteome as the direct targets of the addicted oncogenes in cancer cells</article-title>
        <source>Mol Cell Proteomics</source>
        <year>2014</year>
        <volume>13</volume>
        <issue>1</issue>
        <fpage>49</fpage>
        <lpage>62</lpage>
        <pub-id pub-id-type="doi">10.1074/mcp.M113.027813</pub-id>
        <?supplied-pmid 24105791?>
        <pub-id pub-id-type="pmid">24105791</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Voorhess</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Brecher</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Glicksman</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Krischer</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Boyett</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Forman</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Freeman</surname>
            <given-names>AI</given-names>
          </name>
        </person-group>
        <article-title>Hypothalamic-pituitary function of children with acute lymphocytic leukemia after three forms of central nervous system prophylaxis. A retrospective study</article-title>
        <source>Cancer</source>
        <year>1986</year>
        <volume>57</volume>
        <issue>7</issue>
        <fpage>1287</fpage>
        <lpage>1291</lpage>
        <pub-id pub-id-type="doi">10.1002/1097-0142(19860401)57:7&lt;1287::AID-CNCR2820570706&gt;3.0.CO;2-O</pub-id>
        <?supplied-pmid 3753892?>
        <pub-id pub-id-type="pmid">3753892</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Koskelo</surname>
            <given-names>EK</given-names>
          </name>
          <name>
            <surname>Saarinen</surname>
            <given-names>UM</given-names>
          </name>
          <name>
            <surname>Siimes</surname>
            <given-names>MA</given-names>
          </name>
        </person-group>
        <article-title>Low levels of serum transport proteins indicate catabolic protein status during induction therapy for acute lymphoblastic leukemia</article-title>
        <source>Pediatr Hematol Oncol</source>
        <year>1991</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>53</fpage>
        <lpage>59</lpage>
        <pub-id pub-id-type="doi">10.3109/08880019109033427</pub-id>
        <?supplied-pmid 1903045?>
        <pub-id pub-id-type="pmid">1903045</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Corne</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Bhandari</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Homer</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Elias</surname>
            <given-names>JA</given-names>
          </name>
        </person-group>
        <article-title>Pulmonary expression of leukemia inhibitory factor induces B cell hyperplasia and confers protection in hyperoxia</article-title>
        <source>J Biol Chem</source>
        <year>2003</year>
        <volume>278</volume>
        <issue>33</issue>
        <fpage>31226</fpage>
        <lpage>31232</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.M301820200</pub-id>
        <?supplied-pmid 12782633?>
        <pub-id pub-id-type="pmid">12782633</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pallinger</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Horvath</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Csoka</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kovacs</surname>
            <given-names>GT</given-names>
          </name>
          <name>
            <surname>Csaba</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Decreased hormone content of immune cells in children during acute lymphocytic leukemia (ALL) - effect of treatment</article-title>
        <source>Acta Microbiol Immunol Hung</source>
        <year>2011</year>
        <volume>58</volume>
        <issue>1</issue>
        <fpage>41</fpage>
        <lpage>50</lpage>
        <pub-id pub-id-type="doi">10.1556/AMicr.58.2011.1.5</pub-id>
        <?supplied-pmid 21450554?>
        <pub-id pub-id-type="pmid">21450554</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Abe</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Funato</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Takahashi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yokoyama</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Tomiya</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yamada-Fujiwara</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ishizawa</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kameoka</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kaku</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Increased expression of insulin-like growth factor i is associated with Ara-C resistance in leukemia</article-title>
        <source>Tohoku J Exp Med</source>
        <year>2006</year>
        <volume>209</volume>
        <issue>3</issue>
        <fpage>217</fpage>
        <lpage>228</lpage>
        <pub-id pub-id-type="doi">10.1620/tjem.209.217</pub-id>
        <?supplied-pmid 16778368?>
        <pub-id pub-id-type="pmid">16778368</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ayatollahi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sadeghian</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Keramati</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Karimiani</surname>
            <given-names>EG</given-names>
          </name>
          <name>
            <surname>Jafarian</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Shirdel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rahimi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zangane-Far</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Shajiei</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sheikhi</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>JAK2 V617F mutation in adult T cell leukemia-lymphoma</article-title>
        <source>Indian J Hematol Blood Transfus</source>
        <year>2016</year>
        <volume>32</volume>
        <issue>4</issue>
        <fpage>437</fpage>
        <lpage>441</lpage>
        <pub-id pub-id-type="doi">10.1007/s12288-015-0620-4</pub-id>
        <?supplied-pmid 27812253?>
        <pub-id pub-id-type="pmid">27812253</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vicente</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Vazquez</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Marcotegui</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Conchillo</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Carranza</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Rivell</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bandres</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Cristobal</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Lahortiga</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Calasanz</surname>
            <given-names>MJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>JAK2-V617F activating mutation in acute myeloid leukemia: prognostic impact and association with other molecular markers</article-title>
        <source>Leukemia</source>
        <year>2007</year>
        <volume>21</volume>
        <issue>11</issue>
        <fpage>2386</fpage>
        <lpage>2390</lpage>
        <pub-id pub-id-type="doi">10.1038/sj.leu.2404812</pub-id>
        <?supplied-pmid 17581610?>
        <pub-id pub-id-type="pmid">17581610</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Montero-Ruiz</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Alcantara-Ortigoza</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Betancourt</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Juarez-Velazquez</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gonzalez-Marquez</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Perez-Vera</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Expression of RUNX1 isoforms and its target gene BLK in childhood acute lymphoblastic leukemia</article-title>
        <source>Leuk Res</source>
        <year>2012</year>
        <volume>36</volume>
        <issue>9</issue>
        <fpage>1105</fpage>
        <lpage>1111</lpage>
        <pub-id pub-id-type="doi">10.1016/j.leukres.2012.05.019</pub-id>
        <?supplied-pmid 22748822?>
        <pub-id pub-id-type="pmid">22748822</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lynch</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Brugge</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Fromowitz</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Glantz</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Caruso</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Viola</surname>
            <given-names>MV</given-names>
          </name>
        </person-group>
        <article-title>Increased expression of the src proto-oncogene in hairy cell leukemia and a subgroup of B-cell lymphomas</article-title>
        <source>Leukemia</source>
        <year>1993</year>
        <volume>7</volume>
        <issue>9</issue>
        <fpage>1416</fpage>
        <lpage>1422</lpage>
        <?supplied-pmid 7690441?>
        <pub-id pub-id-type="pmid">7690441</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Machado-Neto</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Favaro</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lazarini</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>da Silva Santos Duarte</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Archangelo</surname>
            <given-names>LF</given-names>
          </name>
          <name>
            <surname>Lorand-Metze</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Costa</surname>
            <given-names>FF</given-names>
          </name>
          <name>
            <surname>Saad</surname>
            <given-names>ST</given-names>
          </name>
          <name>
            <surname>Traina</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>Downregulation of IRS2 in myelodysplastic syndrome: a possible role in impaired hematopoietic cell differentiation</article-title>
        <source>Leuk Res</source>
        <year>2012</year>
        <volume>36</volume>
        <issue>7</issue>
        <fpage>931</fpage>
        <lpage>935</lpage>
        <pub-id pub-id-type="doi">10.1016/j.leukres.2012.03.002</pub-id>
        <?supplied-pmid 22465474?>
        <pub-id pub-id-type="pmid">22465474</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Banerjee</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Mayer-Kuckuk</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Capiaux</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Budak-Alpdogan</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gorlick</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bertino</surname>
            <given-names>JR</given-names>
          </name>
        </person-group>
        <article-title>Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase</article-title>
        <source>Biochim Biophys Acta</source>
        <year>2002</year>
        <volume>1587</volume>
        <issue>2â3</issue>
        <fpage>164</fpage>
        <lpage>173</lpage>
        <pub-id pub-id-type="doi">10.1016/S0925-4439(02)00079-0</pub-id>
        <?supplied-pmid 12084458?>
        <pub-id pub-id-type="pmid">12084458</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kode</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mosialou</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Manavalan</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Rathinam</surname>
            <given-names>CV</given-names>
          </name>
          <name>
            <surname>Friedman</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Teruya-Feldstein</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bhagat</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Berman</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kousteni</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>FoxO1-dependent induction of acute myeloid leukemia by osteoblasts in mice</article-title>
        <source>Leukemia</source>
        <year>2016</year>
        <volume>30</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>13</lpage>
        <pub-id pub-id-type="doi">10.1038/leu.2015.161</pub-id>
        <?supplied-pmid 26108693?>
        <pub-id pub-id-type="pmid">26108693</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Deng</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Xiong</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Xing</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Dong</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics</article-title>
        <source>Breast Cancer Res Treat</source>
        <year>2007</year>
        <volume>104</volume>
        <issue>1</issue>
        <fpage>21</fpage>
        <lpage>30</lpage>
        <pub-id pub-id-type="doi">10.1007/s10549-006-9393-7</pub-id>
        <?supplied-pmid 17004105?>
        <pub-id pub-id-type="pmid">17004105</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Catovsky</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Goldman</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Okos</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Frisch</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Galton</surname>
            <given-names>DA</given-names>
          </name>
        </person-group>
        <article-title>T-lymphoblastic leukaemia: a distinct variant of acute leukaemia</article-title>
        <source>Br Med J</source>
        <year>1974</year>
        <volume>2</volume>
        <issue>5920</issue>
        <fpage>643</fpage>
        <lpage>646</lpage>
        <pub-id pub-id-type="doi">10.1136/bmj.2.5920.643</pub-id>
        <?supplied-pmid 4546214?>
        <pub-id pub-id-type="pmid">4546214</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Marculescu</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Vanura</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Montpellier</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Roulland</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Le</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Navarro</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Jager</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>McBlane</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Nadel</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures</article-title>
        <source>DNA Repair (Amst)</source>
        <year>2006</year>
        <volume>5</volume>
        <issue>9â10</issue>
        <fpage>1246</fpage>
        <lpage>1258</lpage>
        <pub-id pub-id-type="doi">10.1016/j.dnarep.2006.05.015</pub-id>
        <pub-id pub-id-type="pmid">16798110</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schuler</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Szende</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Borsi</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Marton</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Bocsi</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Magyarossy</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Koos</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Csoka</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Apoptosis as a possible way of destruction of lymphoblasts after glucocorticoid treatment of children with acute lymphoblastic leukemia</article-title>
        <source>Pediatr Hematol Oncol</source>
        <year>1994</year>
        <volume>11</volume>
        <issue>6</issue>
        <fpage>641</fpage>
        <lpage>649</lpage>
        <pub-id pub-id-type="doi">10.3109/08880019409141811</pub-id>
        <?supplied-pmid 7857787?>
        <pub-id pub-id-type="pmid">7857787</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moriuchi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Moriuchi</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Induction of lactoferrin gene expression in myeloid or mammary gland cells by human T-cell leukemia virus type 1 (HTLV-1) tax: implications for milk-borne transmission of HTLV-1</article-title>
        <source>J Virol</source>
        <year>2006</year>
        <volume>80</volume>
        <issue>14</issue>
        <fpage>7118</fpage>
        <lpage>7126</lpage>
        <pub-id pub-id-type="doi">10.1128/JVI.00409-06</pub-id>
        <?supplied-pmid 16809317?>
        <pub-id pub-id-type="pmid">16809317</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Quaglino</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schere-Levy</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Romorini</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Meiss</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Kordon</surname>
            <given-names>EC</given-names>
          </name>
        </person-group>
        <article-title>Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling</article-title>
        <source>Breast Cancer Res</source>
        <year>2007</year>
        <volume>9</volume>
        <issue>5</issue>
        <fpage>R69</fpage>
        <pub-id pub-id-type="doi">10.1186/bcr1777</pub-id>
        <?supplied-pmid 17925034?>
        <pub-id pub-id-type="pmid">17925034</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Infante</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Heasman</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Ridley</surname>
            <given-names>AJ</given-names>
          </name>
        </person-group>
        <article-title>Statins inhibit T-acute lymphoblastic leukemia cell adhesion and migration through Rap1b</article-title>
        <source>J Leukoc Biol</source>
        <year>2011</year>
        <volume>89</volume>
        <issue>4</issue>
        <fpage>577</fpage>
        <lpage>586</lpage>
        <pub-id pub-id-type="doi">10.1189/jlb.0810441</pub-id>
        <?supplied-pmid 21233409?>
        <pub-id pub-id-type="pmid">21233409</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>YL</given-names>
          </name>
          <name>
            <surname>Liou</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>YH</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>TY</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>HM</given-names>
          </name>
        </person-group>
        <article-title>A novel tubulin polymerization inhibitor, MPT0B206, downregulates Bcr-Abl expression and induces apoptosis in imatinib-sensitive and imatinib-resistant CML cells</article-title>
        <source>Apoptosis</source>
        <year>2016</year>
        <volume>21</volume>
        <issue>9</issue>
        <fpage>1008</fpage>
        <lpage>1018</lpage>
        <pub-id pub-id-type="doi">10.1007/s10495-016-1264-z</pub-id>
        <?supplied-pmid 27344662?>
        <pub-id pub-id-type="pmid">27344662</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Qin</surname>
            <given-names>LY</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>LG</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Mo</surname>
            <given-names>WN</given-names>
          </name>
        </person-group>
        <article-title>The CCND1 G870A gene polymorphism and leukemia or non-Hodgkin lymphoma risk: a meta-analysis</article-title>
        <source>Asian Pac J Cancer Prev</source>
        <year>2014</year>
        <volume>15</volume>
        <issue>16</issue>
        <fpage>6923</fpage>
        <lpage>6928</lpage>
        <pub-id pub-id-type="doi">10.7314/APJCP.2014.15.16.6923</pub-id>
        <?supplied-pmid 25169547?>
        <pub-id pub-id-type="pmid">25169547</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xue</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Rong</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Tong</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Fang</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>CCND1 G870A polymorphism is associated with toxicity of methotrexate in childhood acute lymphoblastic leukemia</article-title>
        <source>Int J Clin Exp Pathol</source>
        <year>2015</year>
        <volume>8</volume>
        <issue>9</issue>
        <fpage>11594</fpage>
        <lpage>11600</lpage>
        <?supplied-pmid 26617896?>
        <pub-id pub-id-type="pmid">26617896</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>XX</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Wen</surname>
            <given-names>XM</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>ZJ</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Qian</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>High bone marrow ID2 expression predicts poor chemotherapy response and prognosis in acute myeloid leukemia</article-title>
        <source>Oncotarget</source>
        <year>2017</year>
        <volume>8</volume>
        <issue>54</issue>
        <fpage>91979</fpage>
        <lpage>91989</lpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.20559</pub-id>
        <?supplied-pmid 29190891?>
        <pub-id pub-id-type="pmid">29190891</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fancello</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kampen</surname>
            <given-names>KR</given-names>
          </name>
          <name>
            <surname>Hofman</surname>
            <given-names>IJ</given-names>
          </name>
          <name>
            <surname>Verbeeck</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>De Keersmaecker</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types</article-title>
        <source>Oncotarget</source>
        <year>2017</year>
        <volume>8</volume>
        <issue>9</issue>
        <fpage>14462</fpage>
        <lpage>14478</lpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.14895</pub-id>
        <?supplied-pmid 28147343?>
        <pub-id pub-id-type="pmid">28147343</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pavlova</surname>
            <given-names>TV</given-names>
          </name>
          <name>
            <surname>Kashuba</surname>
            <given-names>VI</given-names>
          </name>
          <name>
            <surname>Muravenko</surname>
            <given-names>OV</given-names>
          </name>
          <name>
            <surname>Yenamandra</surname>
            <given-names>SP</given-names>
          </name>
          <name>
            <surname>Ivanova</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Zabarovskaia</surname>
            <given-names>VI</given-names>
          </name>
          <name>
            <surname>Rakhmanaliev</surname>
            <given-names>ER</given-names>
          </name>
          <name>
            <surname>Petrenko</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Pronina</surname>
            <given-names>IV</given-names>
          </name>
          <name>
            <surname>Loginov</surname>
            <given-names>VI</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Technology of analysis of epigenetic and structural changes of epithelial tumors genome with NotI-microarrays by the example of human chromosome</article-title>
        <source>Mol Biol (Mosk)</source>
        <year>2009</year>
        <volume>43</volume>
        <issue>2</issue>
        <fpage>339</fpage>
        <lpage>347</lpage>
        <pub-id pub-id-type="doi">10.1134/S0026893309020137</pub-id>
        <pub-id pub-id-type="pmid">19425501</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bogdanov</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Moiseenko</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Dubina</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Abnormal expression of ATP1A1 and ATP1A2 in breast cancer</article-title>
        <source>F1000Res</source>
        <year>2017</year>
        <volume>6</volume>
        <fpage>10</fpage>
        <pub-id pub-id-type="doi">10.12688/f1000research.10481.1</pub-id>
        <?supplied-pmid 28529692?>
        <pub-id pub-id-type="pmid">28529692</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Annaratone</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Medico</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Rangel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Castellano</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Marchio</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sapino</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bussolati</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Search for neuro-endocrine markers (chromogranin a, synaptophysin and VGF) in breast cancers. An integrated approach using immunohistochemistry and gene expression profiling</article-title>
        <source>Endocr Pathol</source>
        <year>2014</year>
        <volume>25</volume>
        <issue>3</issue>
        <fpage>219</fpage>
        <lpage>228</lpage>
        <pub-id pub-id-type="doi">10.1007/s12022-013-9277-4</pub-id>
        <?supplied-pmid 24277232?>
        <pub-id pub-id-type="pmid">24277232</pub-id>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Soh</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Garrett</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Somji</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Dunlevy</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>XD</given-names>
          </name>
          <name>
            <surname>Sens</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Bathula</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Allen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sens</surname>
            <given-names>DA</given-names>
          </name>
        </person-group>
        <article-title>Arsenic, cadmium and neuron specific enolase (ENO2, gamma-enolase) expression in breast cancer</article-title>
        <source>Cancer Cell Int</source>
        <year>2011</year>
        <volume>11</volume>
        <issue>1</issue>
        <fpage>41</fpage>
        <pub-id pub-id-type="doi">10.1186/1475-2867-11-41</pub-id>
        <?supplied-pmid 22098917?>
        <pub-id pub-id-type="pmid">22098917</pub-id>
      </element-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Dixit</surname>
            <given-names>VM</given-names>
          </name>
        </person-group>
        <article-title>Drugging the undruggables: exploring the ubiquitin system for drug development</article-title>
        <source>Cell Res</source>
        <year>2016</year>
        <volume>26</volume>
        <issue>4</issue>
        <fpage>484</fpage>
        <lpage>498</lpage>
        <pub-id pub-id-type="doi">10.1038/cr.2016.31</pub-id>
        <?supplied-pmid 27002218?>
        <pub-id pub-id-type="pmid">27002218</pub-id>
      </element-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Garg</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Hortobagyi</surname>
            <given-names>GN</given-names>
          </name>
          <name>
            <surname>Aggarwal</surname>
            <given-names>BB</given-names>
          </name>
          <name>
            <surname>Sahin</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Buchholz</surname>
            <given-names>TA</given-names>
          </name>
        </person-group>
        <article-title>Nuclear factor-kappa B as a predictor of treatment response in breast cancer</article-title>
        <source>Curr Opin Oncol</source>
        <year>2003</year>
        <volume>15</volume>
        <issue>6</issue>
        <fpage>405</fpage>
        <lpage>411</lpage>
        <pub-id pub-id-type="doi">10.1097/00001622-200311000-00001</pub-id>
        <?supplied-pmid 14624221?>
        <pub-id pub-id-type="pmid">14624221</pub-id>
      </element-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Prajoko</surname>
            <given-names>YW</given-names>
          </name>
          <name>
            <surname>Aryandono</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Expression of nuclear factor kappa B (NF-kappaB) as a predictor of poor pathologic response to chemotherapy in patients with locally advanced breast cancer</article-title>
        <source>Asian Pac J Cancer Prev</source>
        <year>2014</year>
        <volume>15</volume>
        <issue>2</issue>
        <fpage>595</fpage>
        <lpage>598</lpage>
        <pub-id pub-id-type="doi">10.7314/APJCP.2014.15.2.595</pub-id>
        <?supplied-pmid 24568463?>
        <pub-id pub-id-type="pmid">24568463</pub-id>
      </element-citation>
    </ref>
    <ref id="CR70">
      <label>70.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Curran</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Weinstein</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Griffiths</surname>
            <given-names>LR</given-names>
          </name>
        </person-group>
        <article-title>Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer</article-title>
        <source>Cancer Lett</source>
        <year>2002</year>
        <volume>188</volume>
        <issue>1â2</issue>
        <fpage>103</fpage>
        <lpage>107</lpage>
        <pub-id pub-id-type="doi">10.1016/S0304-3835(02)00460-3</pub-id>
        <?supplied-pmid 12406554?>
        <pub-id pub-id-type="pmid">12406554</pub-id>
      </element-citation>
    </ref>
    <ref id="CR71">
      <label>71.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fu</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>WW</given-names>
          </name>
          <name>
            <surname>Liao</surname>
            <given-names>GS</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>WY</given-names>
          </name>
          <name>
            <surname>Tseng</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Tsai</surname>
            <given-names>YF</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>AL</given-names>
          </name>
        </person-group>
        <article-title>A novel oncogenic role of inositol phosphatase SHIP2 in ER-negative breast cancer stem cells: involvement of JNK/vimentin activation</article-title>
        <source>Stem Cells</source>
        <year>2014</year>
        <volume>32</volume>
        <issue>8</issue>
        <fpage>2048</fpage>
        <lpage>2060</lpage>
        <pub-id pub-id-type="doi">10.1002/stem.1735</pub-id>
        <?supplied-pmid 24802135?>
        <pub-id pub-id-type="pmid">24802135</pub-id>
      </element-citation>
    </ref>
    <ref id="CR72">
      <label>72.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Prasad</surname>
            <given-names>NK</given-names>
          </name>
        </person-group>
        <article-title>SHIP2 phosphoinositol phosphatase positively regulates EGFR-Akt pathway, CXCR4 expression, and cell migration in MDA-MB-231 breast cancer cells</article-title>
        <source>Int J Oncol</source>
        <year>2009</year>
        <volume>34</volume>
        <issue>1</issue>
        <fpage>97</fpage>
        <lpage>105</lpage>
        <?supplied-pmid 19082482?>
        <pub-id pub-id-type="pmid">19082482</pub-id>
      </element-citation>
    </ref>
    <ref id="CR73">
      <label>73.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Prasad</surname>
            <given-names>NK</given-names>
          </name>
          <name>
            <surname>Tandon</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Handa</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Moore</surname>
            <given-names>GE</given-names>
          </name>
          <name>
            <surname>Babbs</surname>
            <given-names>CF</given-names>
          </name>
          <name>
            <surname>Snyder</surname>
            <given-names>PW</given-names>
          </name>
          <name>
            <surname>Bose</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>High expression of obesity-linked phosphatase SHIP2 in invasive breast cancer correlates with reduced disease-free survival</article-title>
        <source>Tumour Biol</source>
        <year>2008</year>
        <volume>29</volume>
        <issue>5</issue>
        <fpage>330</fpage>
        <lpage>341</lpage>
        <pub-id pub-id-type="doi">10.1159/000172970</pub-id>
        <?supplied-pmid 19065064?>
        <pub-id pub-id-type="pmid">19065064</pub-id>
      </element-citation>
    </ref>
    <ref id="CR74">
      <label>74.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xia</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway</article-title>
        <source>Oncol Rep</source>
        <year>2015</year>
        <volume>34</volume>
        <issue>1</issue>
        <fpage>103</fpage>
        <lpage>110</lpage>
        <pub-id pub-id-type="doi">10.3892/or.2015.3979</pub-id>
        <?supplied-pmid 25976617?>
        <pub-id pub-id-type="pmid">25976617</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
